Critical Appraisal on Orbital Decompression for Thyroid Eye Disease: A Systematic Review and Literature Search

Advances in Therapy

Volumn 32, Issue 7, 2015, Pages 595-611

  Boboridis, Konstadinos G ^a,b   Uddin, Jimmy ^b   Mikropoulos, Dimitrios G ^a   Bunce, Catey ^b   Mangouritsas, George ^c   Voudouragkaki, Irini C ^a   Konstas, Anastasios G P ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b MOORFIELDS EYE HOSPITAL   (United Kingdom)

^c IASO GENERAL HOSPITAL   (Greece)

Author keywords

Decompression; DON; Exophthalmos; GO; Graves ; Orbit; Orbitopathy; Strabismus; TED; Thyroid

Indexed keywords

STEROID;

DECOMPRESSION SURGERY; DIPLOPIA; ENDOCRINE OPHTHALMOPATHY; EYE SWELLING; HUMAN; LIQUORRHEA; MULTICENTER STUDY (TOPIC); ORBITAL DECOMPRESSION; PARANASAL SINUS DISEASE; POSTOPERATIVE COMPLICATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; GRAVES OPHTHALMOPATHY; ORBIT; PROCEDURES; RETROSPECTIVE STUDY;

DECOMPRESSION, SURGICAL; GRAVES OPHTHALMOPATHY; HUMANS; ORBIT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES;

EID: 84938417049     PISSN: 0741238X     EISSN: 18658652     Source Type: Journal    
DOI: 10.1007/s12325-015-0228-y     Document Type: Review

References (100)

1. Wiersinga WM, Bartalena L. Epidemiology and prevention of Graves’ ophthalmopathy. Thyroid. 2002;12:855–60.
2. Abraham-Nordling M, Bystrom K, Torring O, et al. Incidence of hyperthyroidism in Sweden. Eur J Endocrinol. 2011;165:899–905.
3. Kendall-Taylor P. The pathogenesis of Graves’ ophthalmopathy. Clin Endocrinol Metab. 1985;14:331–49.
4. Laurberg P, Berman DC, Bulow Pedersen I, et al. Incidence and clinical presentation of moderate to severe Graves’ orbitopathy in a Danish population before and after iodine fortification of salt. J Clin Endocrinol Metab. 2012;97:2325–32.
5. Tanda ML, Piantanida E, Liparulo L, et al. Prevalence and natural history of Graves’ orbitopathy in a large series of patients with newly diagnosed Graves’ hyperthyroidism seen at a single center. J Clin Endocrinol Metab. 2013;98:1443–9.
6. Perros P, Kendall-Taylor P. Thyroid-associated ophthalmopathy: pathogenesis and clinical management. Baillieres Clin Endocrinol Metab. 1995;9:115–35.
7. Krassas GE, Heufelder AE. Immunosuppressive therapy in patients with thyroid eye disease: an overview of current concepts. Eur J Endocrinol. 2001;144:311–8.
8. Bartalena L, Pinchera A, Marcocci C. Management of Graves’ ophthalmopathy: reality and perspectives. Endocr Rev. 2000;21:168–99.
9. Goldberg RA. Advances in surgical rehabilitation in thyroid eye disease. Thyroid. 2008;18:989–95.
10. Wiersinga WM, Prummel MF, Terwee CB. Effects of Graves’ ophthalmopathy on quality of life. J Endocrinol Invest. 2004;27:259–64.
11. Bahn RS. Is orbital decompression a safe and effective treatment for Graves’ orbitopathy? Nat Clin Pract Endocrinol Metab. 2007;3:796–7.
12. Bartalena L. Graves’ orbitopathy: imperfect treatments for a rare disease. Eur Thyroid J. 2013;2:259–69.
13. Dharmasena A, Keenan TD, Goldacre MJ. Orbital decompression for thyroid-associated orbitopathy in England: trends over time and geographical variation. Orbit. 2014;33:109–14.
14. Eckstein A, Schittkowski M, Esser J. Surgical treatment of Graves’ ophthalmopathy. Best Pract Res Clin Endocrinol Metab. 2012;26:339–58.
15. Goldberg RA. The evolving paradigm of orbital decompression surgery. Arch Ophthalmol. 1998;116:95–6.
16. Kim KW, Byun JS, Lee JK. Surgical effects of various orbital decompression methods in thyroid-associated orbitopathy: computed tomography-based comparative analysis. J Craniomaxillofac Surg. 2014;42:1286–91.
17. Marcocci C, Altea MA, Leo M. Treatment options for Graves’ orbitopathy. Expert Opin Pharmacother. 2012;13:795–806.
18. Verity DH, Rose GE. Acute thyroid eye disease (TED): principles of medical and surgical management. Eye (Lond). 2013;27:308–19.
19. Baldeschi L, MacAndie K, Hintschich C, et al. The removal of the deep lateral wall in orbital decompression: its contribution to exophthalmos reduction and influence on consecutive diplopia. Am J Ophthalmol. 2005;140:642–7.
20. Boboridis KG, Gogakos A, Krassas GE. Orbital fat decompression for Graves’ orbitopathy: a literature review. Pediatr Endocrinol Rev. 2010;7(Suppl 2):222–6.
21. O’Malley MR, Meyer DR. Transconjunctival fat removal combined with conservative medial wall/floor orbital decompression for Graves orbitopathy. Ophthal Plast Reconstr Surg. 2009;25:206–10.
22. Boboridis KG, Bunce C. Surgical orbital decompression for thyroid eye disease. Cochrane Database Syst Rev. 2011. doi:10.1002/14651858.CD007630.pub2:CD007630.
23. Fichter N, Guthoff RF, Schittkowski MP. Orbital decompression in thyroid eye disease. ISRN Ophthalmol. 2012;2012:739236.
24. Garrity JA. Orbital lipectomy (fat decompression) for thyroid eye disease: an operation for everyone? Am J Ophthalmol. 2011;151:399–400.
25. Mehta P, Durrani OM. Outcome of deep lateral wall rim-sparing orbital decompression in thyroid-associated orbitopathy: a new technique and results of a case series. Orbit. 2011;30:265–8.
26. Perumal B, Meyer DR. Treatment of severe thyroid eye disease: a survey of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS). Ophthal Plast Reconstr Surg. 2014;. doi:10.1097/IOP.0000000000000216.
27. Prat MC, Braunstein AL, Glass LR, et al. Orbital fat decompression for thyroid eye disease: retrospective case review and criteria for optimal case selection. Ophthal Plast Reconstr Surg. 2014. doi:10.1097/IOP.0000000000000260.
28. European Group on Graves Orbitopathy, Mourits MP, Bijl H, et al. Outcome of orbital decompression for disfiguring proptosis in patients with Graves’ orbitopathy using various surgical procedures. Br J Ophthalmol. 2009;93:1518–23.
29. Hurwitz JJ, Birt D. An individualized approach to orbital decompression in Graves’ orbitopathy. Arch Ophthalmol. 1985;103:660–5.
30. Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. 2009.
31. Marcocci C, Bartalena L, Tanda ML, et al. Comparison of the effectiveness and tolerability of intravenous or oral glucocorticoids associated with orbital radiotherapy in the management of severe Graves’ ophthalmopathy: results of a prospective, single-blind, randomized study. J Clin Endocrinol Metab. 2001;86:3562–7.
32. Prummel MF, Terwee CB, Gerding MN, et al. A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves’ ophthalmopathy. J Clin Endocrinol Metab. 2004;89:15–20.
33. Rajendram R, Lee RW, Potts MJ, et al. Protocol for the combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED) trial: a multi-centre, double-masked, factorial randomised controlled trial. Trials. 2008;9:6.
34. Werner SC. Modification of the classification of the eye changes of Graves’ disease: recommendations of the ad hoc committee of the American Thyroid Association. J Clin Endocrinol Metab. 1977;44:203–4.
35. Prummel MF, Mourits MP, Berghout A, et al. Prednisone and cyclosporine in the treatment of severe Graves’ ophthalmopathy. N Engl J Med. 1989;321:1353–9.
36. Mourits MP, Prummel MF, Wiersinga WM, et al. Clinical activity score as a guide in the management of patients with Graves’ ophthalmopathy. Clin Endocrinol (Oxf). 1997;47:9–14.
37. Terwee CB, Gerding MN, Dekker FW, et al. Development of a disease specific quality of life questionnaire for patients with Graves’ ophthalmopathy: the GO-QOL. Br J Ophthalmol. 1998;82:773–9.
38. Glanville JM, Lefebvre C, Miles JN, et al. How to identify randomized controlled trials in medline: ten years on. J Med Libr Assoc. 2006;94:130–6.
39. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
40. Deeks JJ, Higgins JPT, Altman DG. Analysing data and undertaking meta-analyses. In: Higgins JP, Green S (eds). Cochrane handbook for systematic reviews of interventions Version 510. The Cochrane Collaboration; 2011. http://www.cochrane-handbook.org. Accessed 24 Jan 2015
41. Pliego-Maldonado A, Miranda-Ruiz R, Vargas-Aguayo A, et al. Orbit decompression surgery in patients with exophthalmos caused by Graves-Basedow disease. Gac Med Mex. 2000;136:11–5.
42. Wakelkamp IM, Baldeschi L, Saeed P, et al. Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves’ ophthalmopathy? A randomized controlled trial. Clin Endocrinol (Oxf). 2005;63:323–8.
43. Barkhuysen R, Nielsen CC, Klevering BJ, et al. The transconjunctival approach with lateral canthal extension for three-wall orbital decompression in thyroid orbitopathy. J Craniomaxillofac Surg. 2009;37:127–31.
44. Cansiz H, Yilmaz S, Karaman E, et al. Three-wall orbital decompression superiority to 2-wall orbital decompression in thyroid-associated ophthalmopathy. J Oral Maxillofac Surg. 2006;64:763–9.
45. Chu EA, Miller NR, Grant MP, et al. Surgical treatment of dysthyroid orbitopathy. Otolaryngol Head Neck Surg. 2009;141:39–45.
46. Clauser L, Galie M, Sarti E, et al. Rationale of treatment in Graves ophthalmopathy. Plast Reconstr Surg. 2001;108:1880–94.
47. Russo V, Querques G, Primavera V, et al. Incidence and treatment of diplopia after three-wall orbital decompression in Graves’ ophthalmopathy. J Pediatr Ophthalmol Strabismus. 2004;41:219–25.
48. Thaller SR, Kawamoto HK. Surgical correction of exophthalmos secondary to Graves’ disease. Plast Reconstr Surg. 1990;86:411–8 (discussion 19–21).
49. Kingdom TT, Davies BW, Durairaj VD. Orbital decompression for the management of thyroid eye disease: an analysis of outcomes and complications. Laryngoscope. 2015. doi:10.1002/lary.25320.
50. Gulati S, Ueland HO, Haugen OH, et al. Long-term follow-up of patients with thyroid eye disease treated with endoscopic orbital decompression. Acta Ophthalmol. 2015;93:178–83.
51. Roncevic R, Savkovic Z, Roncevic D. Results of diplopia and strabismus in patients with severe thyroid ophthalmopathy after orbital decompression. Indian J Ophthalmol. 2014;62:268–73.
52. Mainville NP, Jordan DR. Effect of orbital decompression on diplopia in thyroid-related orbitopathy. Ophthal Plast Reconstr Surg. 2014;30:137–40.
53. Fabian ID, Rosen N, Ben Simon GJ. Strabismus after inferior-medial wall orbital decompression in thyroid-related orbitopathy. Curr Eye Res. 2013;38:204–9.
54. Silbert DI, Matta NS, Singman EL. Diplopia secondary to orbital surgery. Am Orthopt J. 2012;62:22–8.
55. Maino AP, Dawson EL, Adams GG, et al. The management of patients with thyroid eye disease after bilateral orbital 3 wall decompression. Strabismus. 2011;19:35–7.
56. Lukas K, Hansrudi N, Alexander S, et al. A step towards individualized, anatomy-based surgical concepts for orbital decompression in Graves’ orbitopathy. Orbit. 2009;28:237–40.
57. Liao SL, Shih MJ, Chang TC, et al. Transforniceal lateral deep bone decompression—a modified technique to prevent postoperative diplopia in patients with disfiguring exophthalmos due to dysthyroid orbitopathy. J Formos Med Assoc. 2006;105:611–6.
58. Goldberg RA, Weinberg DA, Shorr N, et al. Maximal, three-wall, orbital decompression through a coronal approach. Ophthalmic Surg Lasers. 1997;28:832–43.
59. Kakizaki H, Takahashi Y, Ichinose A, et al. The importance of rim removal in deep lateral orbital wall decompression. Clin Ophthalmol. 2011;5:865–9.
60. Ben Simon GJ, Syed HM, Lee S, et al. Strabismus after deep lateral wall orbital decompression in thyroid-related orbitopathy patients using automated hess screen. Ophthalmology. 2006;113:1050–5.
61. Ben Simon GJ, Wang L, McCann JD, et al. Primary-gaze diplopia in patients with thyroid-related orbitopathy undergoing deep lateral orbital decompression with intraconal fat debulking: a retrospective analysis of treatment outcome. Thyroid. 2004;14:379–83.
62. Baril C, Pouliot D, Molgat Y. Optic neuropathy in thyroid eye disease: results of the balanced decompression technique. Can J Ophthalmol. 2014;49:162–6.
63. Cascone P, Rinna C, Reale G, et al. Compression and stretching in Graves orbitopathy: emergency orbital decompression techniques. J Craniofac Surg. 2012;23:1430–3.
64. Choe CH, Cho RI, Elner VM. Comparison of lateral and medial orbital decompression for the treatment of compressive optic neuropathy in thyroid eye disease. Ophthal Plast Reconstr Surg. 2011;27:4–11.
65. Graham SM, Carter KD. Combined endoscopic and subciliary orbital decompression for thyroid-related compressive optic neuropathy. Rhinology. 1997;35:103–7.
66. Korkmaz S, Konuk O. Surgical treatment of dysthyroid optic neuropathy: long-term visual outcomes with comparison of 2-wall versus 3-wall orbital decompression. Curr Eye Res. 2015. doi:10.3109/02713683.2015.1008641:1-6.
67. Perumal B, Meyer DR. Treatment of severe thyroid eye disease: a survey of the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS). Ophthal Plast Reconstr Surg. 2015;31:127–31.
68. Chang EL, Bernardino CR, Rubin PA. Transcaruncular orbital decompression for management of compressive optic neuropathy in thyroid-related orbitopathy. Plast Reconstr Surg. 2003;112:739–47.
69. Eloy P, Trussart C, Jouzdani E, et al. Transnasal endoscopic orbital decompression and Graves’ ophtalmopathy. Acta Otorhinolaryngol Belg. 2000;54:165–74.
70. Hurwitz JJ, Freeman JL, Eplett CJ, et al. Ethmoidectomy decompression for the treatment of Graves’ optic neuropathy. Can J Ophthalmol. 1992;27:283–7.
71. Liao SL, Chang TC, Lin LL. Transcaruncular orbital decompression: an alternate procedure for Graves ophthalmopathy with compressive optic neuropathy. Am J Ophthalmol. 2006;141:810–8.
72. Lv Z, Selva D, Yan W, Daniel P, Tu Y, Wu W. Endoscopical orbital fat decompression with medial orbital wall decompression for dysthyroid optic neuropathy. Curr Eye Res. 2015;1–9. doi:10.3109/02713683.2015.1008640.
73. McCann JD, Goldberg RA, Anderson RL, et al. Medial wall decompression for optic neuropathy but lateral wall decompression with fat removal for non vision-threatening indications. Am J Ophthalmol. 2006;141:916–7.
74. Shorr N, Baylis HI, Goldberg RA, et al. Transcaruncular approach to the medial orbit and orbital apex. Ophthalmology. 2000;107:1459–63.
75. Olivari N. Transpalpebral decompression of endocrine ophthalmopathy (Graves’ disease) by removal of intraorbital fat: experience with 147 operations over 5 years. Plast Reconstr Surg. 1991;87:627–41 (discussion 42–43).
76. Olivari N. Thyroid-associated orbitopathy: transpalpebral decompression by removal of intraorbital fat. Experience with 1362 orbits in 697 patients over 13 years. Exp Clin Endocrinol Diabetes. 1999;107(Suppl 5):S208–11.
77. Richter DF, Stoff A, Olivari N. Transpalpebral decompression of endocrine ophthalmopathy by intraorbital fat removal (Olivari technique): experience and progression after more than 3000 operations over 20 years. Plast Reconstr Surg. 2007;120:109–23.
78. Adenis JP, Robert PY, Lasudry JG, et al. Treatment of proptosis with fat removal orbital decompression in Graves’ ophthalmopathy. Eur J Ophthalmol. 1998;8:246–52.
79. Ferreira MC, Tuma P Jr, Costa MP, et al. Surgical treatment of endocrine exophthalmos by removal of orbital fat: clinical experience. Rev Hosp Clin Fac Med Sao Paulo. 2002;57:217–22.
80. Trokel S, Kazim M, Moore S. Orbital fat removal. Decompression for Graves orbitopathy. Ophthalmology. 1993;100:674–82.
81. Wu CH, Chang TC, Liao SL. Results and predictability of fat-removal orbital decompression for disfiguring Graves exophthalmos in an asian patient population. Am J Ophthalmol. 2008;145:755–9.
82. Kazim M, Trokel SL, Acaroglu G, et al. Reversal of dysthyroid optic neuropathy following orbital fat decompression. Br J Ophthalmol. 2000;84:600–5.
83. Dickersin K, Min YI, Meinert CL. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards. JAMA. 1992;267:374–8.
84. Takahashi Y, Kakizaki H. Horizontal eye position in thyroid eye disease: a retrospective comparison with normal individuals and changes after orbital decompression surgery. PLoS One. 2014;9:e114220.
85. Hill RH, Czyz CN, Bersani TA. Transcaruncular medial wall orbital decompression: an effective approach for patients with unilateral Graves ophthalmopathy. Sci World J. 2012;2012:312361.
86. Unal M, Leri F, Konuk O, et al. Balanced orbital decompression combined with fat removal in Graves ophthalmopathy: do we really need to remove the third wall? Ophthal Plast Reconstr Surg. 2003;19:112–8.
87. Asaria RH, Koay B, Elston JS, et al. Endoscopic orbital decompression for thyroid eye disease. Eye (Lond). 1998;12(Pt 6):990–5.
88. Cruz AA, Leme VR. Orbital decompression: a comparison between trans-fornix/transcaruncular inferomedial and coronal inferomedial plus lateral approaches. Ophthal Plast Reconstr Surg. 2003;19:440–5 (discussion 45).
89. Lee KY, Ang BT, Ng I, et al. Stereotaxy for surgical navigation in orbital surgery. Ophthal Plast Reconstr Surg. 2009;25:300–2.
90. Millar MJ, Maloof AJ. The application of stereotactic navigation surgery to orbital decompression for thyroid-associated orbitopathy. Eye (Lond). 2009;23:1565–71.
91. Wu CY, Kahana A. Stereotactic navigation with a registration mask in orbital decompression surgery: preliminary results. Ophthal Plast Reconstr Surg. 2015;. doi:10.1097/IOP.0000000000000369.
92. Cho RI, Choe CH, Elner VM. Ultrasonic bone removal versus high-speed burring for lateral orbital decompression: comparison of surgical outcomes for the treatment of thyroid eye disease. Ophthal Plast Reconstr Surg. 2010;26:83–7.
93. Nguyen J, Fay A, Yadav P, et al. Stereotactic microdebrider in deep lateral orbital decompression for patients with thyroid eye disease. Ophthal Plast Reconstr Surg. 2014;30:262–6.
94. Ponto KA, Zwiener I, Al-Nawas B, et al. Piezosurgery for orbital decompression surgery in thyroid associated orbitopathy. J Craniomaxillofac Surg. 2014;42:1813–20.
95. Rocchi R, Lenzi R, Marino M, et al. Rehabilitative orbital decompression for Graves’ orbitopathy: risk factors influencing the new onset of diplopia in primary gaze, outcome and patients’ satisfaction. A large retrospective study. Thyroid. 2012;. doi:10.1089/thy.2012-0272.
96. Murchison AP, Schaberg M, Rosen MR, et al. Large meningoencephalocele after orbital decompression. Ophthal Plast Reconstr Surg. 2012;28:e64–5.
97. Baldeschi L. Small versus coronal incision orbital decompression in Graves’ orbitopathy. Orbit. 2009;28:231–6.
98. Goldberg RA, Perry JD, Hortaleza V, et al. Strabismus after balanced medial plus lateral wall versus lateral wall only orbital decompression for dysthyroid orbitopathy. Ophthal Plast Reconstr Surg. 2000;16:271–7.
99. Stark B, Olivari N. Treatment of exophthalmos by orbital fat removal. Clin Plast Surg. 1993;20:285–9 (discussion 90).
100. Kazim M, Trokel SL, Acaroglu G, et al. Reversal of dysthyroid optic neuropathy following orbital fat decompression. Br J Ophthalmol. 2000;84:600–5.